Thirty healthy individuals and 23 patients with coronary artery disease (CAD) verfied by coronary angiography were examined at the time of stenting and 6 months after percutaneous transluminal coronary angioplasty (PTCA) followed by intravascular ultrasound ( IVUS)-guided stenting and treatment with statins. Analysis of IVUS volumetric measurement for all stented segments after 6 months showed a small but significant decrease of mean minimal square area (18.39%), mean minimal lumen diameter ( 12.77%), and mean minimal lumen volume (12.66%), if compared with values obtained at the time of stenting. Before stenting we observed an increase of serum triglycerides, total cholesterol, low density lipoprotein cholesterol (LDL-cholesterol) concentrations, cholesterol to phospholipid ratio and the percentage of saturated fatty acids in phospholipids, while serum high density lipoprotein cholesterol (HDL-cholesterol) and phospholipids concentrations as well as the percentage of unsaturated fatty acid in phospholipids were lowered. Six months after stenting and treatment with statins a significant increase of HDL-cholesterol was found, while other indices of lipids mentioned above remained unchanged. Before stenting we have also observed increased scrum concentration of C'-reactive protein (CRP), neopterin, total homocysteine, and kynurenine concentrations, while pyridoxal-5-phosphate (P-5-P) concentration was lowered. Six months after stenting and treatment with statins, CRP, neopterin, homocysteine, and P-5-P serum concentrations remained unchanged, while kynurenine concentration increased (P <0.02). The results of this study as well as data of our previous investigations suggest that improvement of blood circulation of the heart muscle due to stenting does not normalise intercellular metabolism in patient with CAD. Some improvement observed in lipid metabolism can be the result of treatment with statins, although these changes in lipid metabolism were not followed by improvement of other biochemical indices examined in CAD patients of this study. At present the role of kynurenine in the course of CAD is obscure. Therefore further investigations are necessary.
Introduction
Necropsy studies of young adults who had died in military combat (1) , and intravascular ultrasound (IVUS) assessment of young adults killed in automobile accident, whose hearts were harvested for transplantation, revealed a remarkably high incidence of asymptomatic atherosclerosis (2) . Therefore IVUS findings have been interpreted as early indication of atherosclerosis development and progression of blood vessels especially in general and coronary artery disease (CAD) (3), Data of literature as well as results of our previous studies have shown that CAD is associated with elevated blood concentrations of C-reactive Correspondence to: Prof.Dr. Vera Rudzite, Latvian Institute of Cardiology, 13 Pilsonu Street, 1002 Riga, Latvia, Tel +371 2 7610987, Fax +371 761 4641, e-mail jana.rizaM inbox.lv protein (CRP), neopterin (4-7), homocysteine (7) (8) (9) , kynurenine (10, 11) , triglycerides, total cholesterol, low-density lipoprotein-(LDL»-cholesterol, as well as cholesterol to phospholipids ratio and saturated fatty acid percentage in phospholipids (12) , while pyridoxal-5-phosphate (P-5-P) (7, 13) , and high-density lipoprotein^HDL (-cholesterol concentrations as well as the percentage of unsaturated fatty acid in phospholipids are decreased (12) . The aim of this study was to compare biochemical indices mentioned above with data of IVUS at the time of angioplasty followed by stenting and after 6 months in patients with CAD.
Materials and Methods
Thirty healthy individuals and 23 patients with CAD (18 men, 5 women, 30-79 years old; 1-artery disease: n=13; 2-artery disease: n=8; 3-artery disease: n=2 patients), were included in this study; 13 patients were smokers, 19 had hypertension and 5 patients had a family history of CAD; 12 patients were after Q-wave myocardial infarction, and 5 patients after non-Q-wave myocardial infarction. In therapeutic doses, aspirin was used in all patients, 20 patients received betablockers, ACE-inhibitors were used in 21 patients, nitrites (n=14), calcium antagonists (nv=2), and statins: Sortis or Zokor (n=20). Angioplasty followed by stent implantation on anterior descending artery domain (LAD) was performed in 17 patients, on left measurements were performed by two independent observers (14) . Neopterin (BRAHMS, Berlin, Germany), total homocysteine (Abbot IMx), high sensitivity CRP, triglycerides, total cholesterol, HDL-cholesterol (Dade Behring) were measured by immunoassay according to manufacturers' instructions. If triglycerides concentration was <6 mmol/L, LDL-cholesterol was calculated using Friedewald formula. P-5-P concentration was determined by Serfontcin and others (13) , kynurenine by HPLC (15) . After extraction of lipids by Folch and others (16) , the method of Urbach and Raabe (17) was used to estimate concentration of phospholipids. The method of Kates (18)) was used to prepare fatty acids content in phospholipids using gas chromatography. The convential technique of gas chromatography for fatty acid methylesters was applied where carrier gas was helium and the sorbent was DE AG. The distribution of fatty acid methylesters was obtained at 210" C using flame ionisation detection with adequate speed of helium.
Statistical comparisons were performed using Student's paired and non-paired t-test. Ρ values <0.05 were considered to indicate significant differences. The study was approved by the Ethics Committee of Latvian Council of Sciences. Table 1 shows the data of IVUS measurements at Table 2 ) is associated with an increase of total cholesterol, LDL-cholesterol, CRP, neopterin, total homocysteine, and kynurenine concentrations in blood serum as well as cholesterol/phospholipids ratio and the percentage of saturated fatty acids in phospholipids, while HDL-cholesterol, phospholipids, P-5-P concentrations as well as the percentage of unsaturated fatty acid in phospholipids are lowered.
Results
Among lipid parameters we have only observed an Pteridines/Vol. 17/No. 3 52.4 ± 14.0 19.9 ± 8.14 increase or normalisation of HDL-cholesterol concentration in blood serum 6 months after stenting (see Table 3 ), whereas the others did not change significantly when compared with values obtained before stenting.
Comparison of CRP, ncopterin, homocysteine, kynurenine and P-5-P concentrations in blood serum 6 months after stenting with values obtained before stent implantation (see Table 4 ) shows only an increase of kynurenine concentration (P<0.02). Changes of other indices 6 months after stent implantation are not statistically significant. 5 ± 1.0 5+1.5 Table 3 . Concentrations and percentages of lipids (mean ± SD) in patients with coronary artery disease (CAD) before (n=23) and 6 months (n-23) after percutaneous transluminal coronary angioplasty (PTCA) followed by stent implantation and treatment with statins (HDL: high density lipoprotein: LDL: low density lipoprotein; **p <0.01, all other differences not significant) Ptcridines/Vol. 1 7/No. 3 Table 4 . Concentrations (mean ± SD) of C-reactive protein, neoptenn, total homocysteine, kynurenine and pyridoxal-5-phosphate in blood serum before (n=23) and 6 month after (n=23) percutaneous transluminal coronary angioplasty (PTCA) followed by stent implantation (*p <0.05, all other différences not significant) (12.8 %) , and mean loss of MLV was 2 1.7 ± 16.4 mm3 (12.7 %). Therefore our results received by IVUS 6 months after stent implantation was good (20, 2 1 ). The biochemical indices in blood serum before percutaneous transluminal coronary angioplasty (PTCA) such as total cholesterol, LDL-cholesterol, triglycerides, cholesterol/phospholipids ratio, saturated fatty acid content in phospholipids, CRP. neoptcrin. homocysteine, kynurenine were elevated, while HDL-cholestcrol, phospholipids, unsaturated fatty acid content in phospholipids and P-5-P concentrations were lowered. This result corresponds well with data of our prev ious investigations (7, 11, 12, 22) .
CAD
Six months after stent implantation and treatment with statins we observed an increase or normalisation of HDL-cholesterol concentration (see Table 3 ) and an elevation of kynurenine levels (see Table 4 ) in blood serum of our CAD patients. The other changes of lipid parameters (see Table 3 ) as well as other risk factors, e.g., a decline of neopterin concentrations (see Table  4 ), did not reach the level of significance if compared with values obtained before PTCA. Data suggests that an increase or normalisation of HDL-cholesterol observed in blood serum 6 months after stent implantation was due to treatment with statins of our CAD patients. The increase of kynurenine concentration within 6 months after stenting was higher than that observed in healthy aged individuals within 10 years (23) . At present the role of kynurenine in the development and progression of CAD is obscure. Therefore further investigations are necessary. The results of this study as well as data of our previous investigations (22) allow to conclude that improvement of circulation in heart muscle due to PCTA followed by stent implantation does not normalise intercellular metabolism found in CAD. The treatment with statins is followed by an elevation of the HDL-cholestcrol concentration in serum, but these changes in lipid metabolism have no effect on other risk factors determined in blood scrum of CAD patients.
